celiprolol has been researched along with Stroke in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K | 1 |
| Kashihara, H | 1 |
| Hosozawa, KI | 1 |
| Tamura, M | 1 |
| Baba, S | 1 |
| Iwasaki, Y | 1 |
1 other study available for celiprolol and Stroke
| Article | Year |
|---|---|
Concurrent dolichoectasia of basilar and coronary arteries.
Topics: Age of Onset; Aged; Aged, 80 and over; Antihypertensive Agents; Basilar Artery; Celiprolol; Coronary | 2006 |